SD Biosensor Inc
KRX:137310
SD Biosensor Inc
Common Stock
SD Biosensor Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
SD Biosensor Inc
KRX:137310
|
Common Stock
â‚©62.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Common Stock
â‚©29B
|
CAGR 3-Years
110%
|
CAGR 5-Years
58%
|
CAGR 10-Years
N/A
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Common Stock
â‚©65.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
27%
|
CAGR 10-Years
17%
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Common Stock
â‚©4.5B
|
CAGR 3-Years
22%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
H
|
Humasis Co Ltd
KOSDAQ:205470
|
Common Stock
â‚©13B
|
CAGR 3-Years
56%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
I
|
Interojo Co Ltd
KOSDAQ:119610
|
Common Stock
â‚©6.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
2%
|
SD Biosensor Inc
Glance View
SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. The company is headquartered in Suwon, Gyeonggi-Do. The company went IPO on 2021-07-16. The firm is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The firm is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The firm distributes its products within domestic market and to overseas markets.
See Also
What is SD Biosensor Inc's Common Stock?
Common Stock
62.2B
KRW
Based on the financial report for Dec 31, 2023, SD Biosensor Inc's Common Stock amounts to 62.2B KRW.
What is SD Biosensor Inc's Common Stock growth rate?
Common Stock CAGR 3Y
10%
Over the last year, the Common Stock growth was 19%. The average annual Common Stock growth rates for SD Biosensor Inc have been 10% over the past three years .